loading

Marker Therapeutics Inc Borsa (MRKR) Ultime notizie

pulisher
Mar 14, 2025

12 Health Care Stocks Moving In Friday's Pre-Market Session - Benzinga

Mar 14, 2025
pulisher
Mar 11, 2025

MRKR stock touches 52-week low at $1.35 amid market challenges - Investing.com Australia

Mar 11, 2025
pulisher
Mar 11, 2025

MRKR stock touches 52-week low at $1.35 amid market challenges By Investing.com - Investing.com South Africa

Mar 11, 2025
pulisher
Mar 07, 2025

Canaccord Genuity Group Initiates Coverage on Marker Therapeutics (NASDAQ:MRKR) - Defense World

Mar 07, 2025
pulisher
Mar 06, 2025

Pre-market Movers: PRFX, BJDX, TARA, PBM... - RTTNews

Mar 06, 2025
pulisher
Mar 05, 2025

This Krystal Biotech Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday - Benzinga India

Mar 05, 2025
pulisher
Mar 05, 2025

Canaccord Genuity Initiates Coverage of Marker Therapeutics (MRKR) with Buy Recommendation - Nasdaq

Mar 05, 2025
pulisher
Mar 05, 2025

Marker Therapeutics initiated with a Buy at Canaccord - TipRanks

Mar 05, 2025
pulisher
Mar 03, 2025

MRKR stock touches 52-week low at $1.45 amid market challenges - Investing.com India

Mar 03, 2025
pulisher
Mar 03, 2025

MRKR stock touches 52-week low at $1.45 amid market challenges By Investing.com - Investing.com South Africa

Mar 03, 2025
pulisher
Feb 25, 2025

Marker Therapeutics to Present at the H.C. Wainwright 3rd Annual Cell Therapy Virtual Conference - GlobeNewswire

Feb 25, 2025
pulisher
Feb 25, 2025

Will Marker Therapeutics Reveal New Clinical Data at Upcoming Cell Therapy Conference? - StockTitan

Feb 25, 2025
pulisher
Feb 24, 2025

MRKR stock touches 52-week low at $1.48 amid market challenges - Investing.com India

Feb 24, 2025
pulisher
Feb 24, 2025

MRKR stock touches 52-week low at $1.48 amid market challenges By Investing.com - Investing.com South Africa

Feb 24, 2025
pulisher
Feb 20, 2025

Marker Therapeutics grants stock options to CEO and directors By Investing.com - Investing.com South Africa

Feb 20, 2025
pulisher
Feb 20, 2025

Marker Therapeutics grants stock options to CEO and directors - Investing.com India

Feb 20, 2025
pulisher
Feb 15, 2025

Marker Therapeutics (MRKR) Stock Price, News & Analysis - MarketBeat

Feb 15, 2025
pulisher
Feb 14, 2025

Analysts Offer Predictions for MRKR FY2024 Earnings - Defense World

Feb 14, 2025
pulisher
Feb 13, 2025

Marker Therapeutics (NASDAQ:MRKR) Upgraded at Brookline Capital Management - Defense World

Feb 13, 2025
pulisher
Feb 12, 2025

Brookline Capital sets $4 target on Marker Therapeutics stock - MSN

Feb 12, 2025
pulisher
Feb 12, 2025

MRKR stock touches 52-week low at $1.61 amid market challenges - Investing.com Nigeria

Feb 12, 2025
pulisher
Feb 11, 2025

Brookline Capital sets $4 target on Marker Therapeutics stock By Investing.com - Investing.com Australia

Feb 11, 2025
pulisher
Feb 11, 2025

H.C. Wainwright maintains Buy on OKYO Pharma with $7 target - MSN

Feb 11, 2025
pulisher
Feb 11, 2025

MRKR stock touches 52-week low at $1.61 amid market challenges By Investing.com - Investing.com South Africa

Feb 11, 2025
pulisher
Feb 11, 2025

Marker Therapeutics (NASDAQ:MRKR) Stock Price Down 2.8% – Here’s Why - Defense World

Feb 11, 2025
pulisher
Feb 07, 2025

Cytokinetics draws new Buy from Citi on aficamten potential - MSN

Feb 07, 2025
pulisher
Feb 05, 2025

Biotech Analysis Central Model 10+ Portfolio Pick#16 Marker Therapeutics; MT-601 Lymphoma Data 2nd Half Of 2024, Study Initiation Of OTS MT-401 For AML And Catalysts (NASDAQ:MRKR) - Seeking Alpha

Feb 05, 2025
pulisher
Feb 03, 2025

Marker Therapeutics Announces Board Resignation - MSN

Feb 03, 2025
pulisher
Feb 01, 2025

MRKR stock touches 52-week low at $1.8 amid market challenges - MSN

Feb 01, 2025
pulisher
Jan 30, 2025

Marker Therapeutics Announces Board Resignation By Investing.com - Investing.com Nigeria

Jan 30, 2025
pulisher
Jan 29, 2025

Marker Therapeutics pops on receiving $9.5M grant to advance lead asset - MSN

Jan 29, 2025
pulisher
Jan 24, 2025

Hematopoietic Stem Cell Transplantation Market: Soaring - openPR

Jan 24, 2025
pulisher
Jan 22, 2025

MRKR stock touches 52-week low at $2.4 amid challenging year - MSN

Jan 22, 2025
pulisher
Jan 21, 2025

MRKR stock touches 52-week low at $2.4 amid challenging year By Investing.com - Investing.com South Africa

Jan 21, 2025
pulisher
Jan 18, 2025

Marker Therapeutics (NASDAQ:MRKR) Shares Down 7.5% – What’s Next? - Defense World

Jan 18, 2025
pulisher
Jan 17, 2025

SEC Form 424B3 filed by Marker Therapeutics Inc. - Quantisnow

Jan 17, 2025
pulisher
Jan 14, 2025

BostonGene Evaluates Novel Therapies and Immune System Profiling as a Marker of Response in Patients with Gastrointestinal Cancers - Business Wire

Jan 14, 2025
$307.24
price up icon 0.61%
$76.55
price up icon 1.97%
$32.77
price up icon 0.28%
$20.79
price up icon 8.34%
$99.47
price up icon 2.06%
biotechnology ONC
$259.19
price up icon 1.81%
Capitalizzazione:     |  Volume (24 ore):